Your browser doesn't support javascript.
loading
Phase-Dependent Suppression of Beta Oscillations in Parkinson's Disease Patients.
Holt, Abbey B; Kormann, Eszter; Gulberti, Alessandro; Pötter-Nerger, Monika; McNamara, Colin G; Cagnan, Hayriye; Baaske, Magdalena K; Little, Simon; Köppen, Johannes A; Buhmann, Carsten; Westphal, Manfred; Gerloff, Christian; Engel, Andreas K; Brown, Peter; Hamel, Wolfgang; Moll, Christian K E; Sharott, Andrew.
Affiliation
  • Holt AB; MRC Brain Network Dynamics Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom.
  • Kormann E; MRC Brain Network Dynamics Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom.
  • Gulberti A; Departments of Neurophysiology and Pathophysiology.
  • Pötter-Nerger M; Neurology, and.
  • McNamara CG; MRC Brain Network Dynamics Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom.
  • Cagnan H; MRC Brain Network Dynamics Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom.
  • Baaske MK; Institute of Neurology, University College London, London WC1N 3BG, United Kingdom.
  • Little S; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, United Kingdom.
  • Köppen JA; MRC Brain Network Dynamics Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom.
  • Buhmann C; Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, London WC1E 6BT, United Kingdom, and.
  • Westphal M; Neurosurgery, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
  • Gerloff C; Neurology, and.
  • Engel AK; Neurosurgery, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
  • Brown P; Neurology, and.
  • Hamel W; Departments of Neurophysiology and Pathophysiology.
  • Moll CKE; MRC Brain Network Dynamics Unit, Department of Pharmacology, University of Oxford, Oxford OX1 3TH, United Kingdom.
  • Sharott A; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, United Kingdom.
J Neurosci ; 39(6): 1119-1134, 2019 02 06.
Article in En | MEDLINE | ID: mdl-30552179
ABSTRACT
Synchronized oscillations within and between brain areas facilitate normal processing, but are often amplified in disease. A prominent example is the abnormally sustained beta-frequency (∼20 Hz) oscillations recorded from the cortex and subthalamic nucleus of Parkinson's disease patients. Computational modeling suggests that the amplitude of such oscillations could be modulated by applying stimulation at a specific phase. Such a strategy would allow selective targeting of the oscillation, with relatively little effect on other activity parameters. Here, activity was recorded from 10 awake, parkinsonian patients (6 male, 4 female human subjects) undergoing functional neurosurgery. We demonstrate that stimulation arriving on a particular patient-specific phase of the beta oscillation over consecutive cycles could suppress the amplitude of this pathophysiological activity by up to 40%, while amplification effects were relatively weak. Suppressive effects were accompanied by a reduction in the rhythmic output of subthalamic nucleus (STN) neurons and synchronization with the mesial cortex. While stimulation could alter the spiking pattern of STN neurons, there was no net effect on firing rate, suggesting that reduced beta synchrony was a result of alterations to the relative timing of spiking activity, rather than an overall change in excitability. Together, these results identify a novel intrinsic property of cortico-basal ganglia synchrony that suggests the phase of ongoing neural oscillations could be a viable and effective control signal for the treatment of Parkinson's disease. This work has potential implications for other brain diseases with exaggerated neuronal synchronization and for probing the function of rhythmic activity in the healthy brain.SIGNIFICANCE STATEMENT In Parkinson's disease (PD), movement impairment is correlated with exaggerated beta frequency oscillations in the cerebral cortex and subthalamic nucleus (STN). Using a novel method of stimulation in PD patients undergoing neurosurgery, we demonstrate that STN beta oscillations can be suppressed when consecutive electrical pulses arrive at a specific phase of the oscillation. This effect is likely because of interrupting the timing of neuronal activity rather than excitability, as stimulation altered the firing pattern of STN spiking without changing overall rate. These findings show the potential of oscillation phase as an input for "closed-loop" stimulation, which could provide a valuable neuromodulation strategy for the treatment of brain disorders and for elucidating the role of neuronal oscillations in the healthy brain.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Beta Rhythm Type of study: Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Neurosci Year: 2019 Document type: Article Affiliation country: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Beta Rhythm Type of study: Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Neurosci Year: 2019 Document type: Article Affiliation country: Reino Unido